Patent office data show robust and rising patenting of AI inventions in the medical field, contrary to fears that medical machine learning patents might be largely unavailable because of challenges to their subject-matter eligibility.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
US Food & Drug Administration. Artificial Intelligence and Machine Learning (AI/ML)-Enabled Medical Devices (5 October 2022); https://www.fda.gov/medical-devices/software-medical-device-samd/artificial-intelligence-and-machine-learning-aiml-enabled-medical-devices
Price, N. Cardozo Law Rev. 37, 1401–1453 (2017).
Tull, S. & Miller, P. J. Rob. Artif. Intell. Law 1, 315–325 (2018).
Aboy, M. et al. Nat. Biotechnol. 37, 1118–1125 (2019).
Williams, H. Annu. Rev. Econ. 9, 441–469 (2017).
Bubela, T. et al. Nat. Biotechnol. 31, 202–206 (2013).
Smith, J. A. et al. Nat. Biotechnol. 36, 1043–1047 (2018).
Aboy, M., Minssen, T. & Kop, M. Rev. Intellect. Prop. Compet. Law 53, 853–882 (2022).
Aboy, M., Liddell, K., Liddicoat, J. & Crespo, C. Nat. Biotechnol. 34, 1119–1123 (2016).
Aboy, M., Liddicoat, J., Liddell, K., Jordan, M. & Crespo, C. Nat. Biotechnol. 35, 820–825 (2017).
Aboy, M., Liddell, K., Jordan, M., Crespo, C. & Liddicoat, J. Nat. Biotechnol. 40, 465–471 (2022).
Aboy, M., Crespo, C., Liddell, K., Minssen, T. & Liddicoat, J. Nat. Biotechnol. 37, 513–518 (2019).
Reuter, E. 5 takeaways from the FDA’s list of AI-enabled medical devices. MedTech Dive https://www.medtechdive.com/news/FDA-AI-ML-medical-devices-5-takeaways/635908/ (7 November 2022).
Minssen, T., Gerke, S., Aboy, M., Price, N. & Cohen, G. J. Law Biosci. 7, lsaa002 (2020).
US Food & Drug Administration. Clinical Decision Support Software: Guidance for Industry and Food and Drug Administration Staff (28 September 2022); https://www.fda.gov/regulatory-information/search-fda-guidance-documents/clinical-decision-support-software
Acknowledgements
The research was supported, in part, by a Novo Nordisk Foundation Grant for a scientifically independent International Collaborative Biomedical Innovation & Law Program - Inter-CeBIL (grant no. NNF17SA027784, Cantab. grant no. G122163). We would like to acknowledge Liz Aboy for her valuable contribution and technical support generating figures for this article.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Supplementary information
Supplementary Information
Supplementary Data
Rights and permissions
About this article
Cite this article
Aboy, M., Price, W.N. & Raker, S. Mapping the patent landscape of medical machine learning. Nat Biotechnol 41, 461–468 (2023). https://doi.org/10.1038/s41587-023-01735-6
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41587-023-01735-6